Joseph Loscalzo

Board Member · IONIS PHARMACEUTICALS INC

Rank #18,396 SEC EDGAR (United States) ↗ Files from United States

Details

Member of the boardPharmaceuticals & BiotechnologyIONSSEC CIK 0001276128

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$2.5M
1-day change
▲ 0.96%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 2 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$2.0M – $3.3M2026-09-04

Insider activity Jul 15, 2024 – Mar 13, 2026

Joseph Loscalzo is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 13 transactions between Jul 15, 2024 and Mar 13, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$2.76M
5 sales on file priced rows only
All reported transactions
13
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 21 most recent rows are grouped into 14 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. IONIS PHARMACEUTICALS INC IONS S Open-market sale × 2 77,289 shares $5.80M
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    17,781 $75.58 $1.34M SEC filing ↗
    59,508 $74.90 $4.46M SEC filing ↗
  2. IONIS PHARMACEUTICALS INC IONS M Option exercise or conversion × 6not a buy/sell decision 77,289 shares $3.77M
    The 6 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    16,000 $64.80 $1.04M SEC filing ↗
    12,000 $60.20 $722.4K SEC filing ↗
    16,000 $42.88 $686.1K SEC filing ↗
    10,321 $41.08 $424.0K SEC filing ↗
    12,000 $40.05 $480.6K SEC filing ↗
    10,968 $38.06 $417.4K SEC filing ↗
  3. CYPHERPUNK TECHNOLOGIES INC. CYPH M Option exercise or conversion × 2not a buy/sell decisionreported at zero 168,750 shares $0
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    94,050 $0.00reported at zero $0 SEC filing ↗
    74,700 $0.00reported at zero $0 SEC filing ↗
  4. IONIS PHARMACEUTICALS INC IONS S Open-market sale 200 shares $16.0K at $80.00 SEC filing ↗
  5. IONIS PHARMACEUTICALS INC IONS M Option exercise or conversionnot a buy/sell decision 200 shares $7.6K at $38.06 SEC filing ↗
  6. IONIS PHARMACEUTICALS INC IONS S Open-market sale 832 shares $66.8K at $80.33 SEC filing ↗
  7. IONIS PHARMACEUTICALS INC IONS M Option exercise or conversionnot a buy/sell decision 832 shares $31.7K at $38.06 SEC filing ↗
  8. IONIS PHARMACEUTICALS INC IONS M Option exercise or conversionnot a buy/sell decision 16,000 shares $835.5K at $52.22 SEC filing ↗
  9. IONIS PHARMACEUTICALS INC IONS S Open-market sale 16,000 shares $1.20M at $75.10 SEC filing ↗
  10. IONIS PHARMACEUTICALS INC IONS M Option exercise or conversionnot a buy/sell decision 16,000 shares $390.7K at $24.42 SEC filing ↗
  11. IONIS PHARMACEUTICALS INC IONS S Open-market sale 16,000 shares $962.4K at $60.15 SEC filing ↗
  12. IONIS PHARMACEUTICALS INC IONS M Option exercise or conversionnot a buy/sell decisionreported at zero 4,079 shares $0 at $0.00 SEC filing ↗
  13. IONIS PHARMACEUTICALS INC IONS S Open-market sale 13,508 shares $511.4K at $37.86 SEC filing ↗
  14. IONIS PHARMACEUTICALS INC IONS M Option exercise or conversionnot a buy/sell decisionreported at zero 4,677 shares $0 at $0.00 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
IONIS PHARMACEUTICALS INC IONS Common Stock 36,330 $58.09 $2.1M 4 EDGAR ↗
CYPHERPUNK TECHNOLOGIES INC. CYPH Common Stock 168,750 $2.42 $408.4K 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Joseph Loscalzo reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.